Walleye Capital’s Starling Oncology, Inc. Warrant STLNW Stock Holding History

Walleye Capital’s Portfolio STLNW Stock Details STLNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-53,902	Closed	-$280	–	5134
2024 Q4	$280	Sell	53,902 -339,643	-86%	-$5.3K	﹤0.01%	4735
2024 Q3	$7.87K	Hold	393,545	–	–	﹤0.01%	4946
2024 Q2	$10.3K	Hold	393,545	–	–	﹤0.01%	5219
2024 Q1	$78.7K	Hold	393,545	–	–	﹤0.01%	4508
2023 Q4	$51.2K	Buy	393,545 +60,208	+18%	+$9.51K	﹤0.01%	4290
2023 Q3	$30.6K	Sell	333,337 -176,778	-35%	-$14.4K	﹤0.01%	4309
2023 Q2	$14.2K	Buy	510,115 +30,242	+6%	+$1.66K	﹤0.01%	3863
2023 Q1	$31.2K	Buy	479,873 +124,463	+35%	+$15.4K	﹤0.01%	3300
2022 Q4	$39.1K	Buy	+355,410	New	+$116K	﹤0.01%	2576

Other funds holding STLNW

LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

AGM

Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return

FreeGulliver LLC New Orleans, Louisiana $237M AUM 21.92% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

Walleye Capital's STLNW Position: Q1 2025 in Review

Walleye Capital sold out of Starling Oncology, Inc. Warrant (STLNW) in Q1 2025, closing a stake of 53,902 shares — an estimated $280 sold.

Walleye Capital first reported a position in STLNW in Q4 2022 and held it in 9 quarters. The position peaked at $78.7K in Q1 2024. 11 funds tracked by Wall St. Rank hold STLNW as of Q1 2025.

Walleye Capital reported no remaining Starling Oncology, Inc. Warrant position as of Q1 2025 after selling out during the quarter.
Walleye Capital sold 53,902 Starling Oncology, Inc. Warrant shares in Q1 2025, an estimated $280.
Walleye Capital first reported a position in Starling Oncology, Inc. Warrant in Q4 2022 and held it in 9 quarters.
Walleye Capital's Starling Oncology, Inc. Warrant position peaked at $78.7K in Q1 2024.
11 funds tracked by Wall St. Rank held Starling Oncology, Inc. Warrant as of Q1 2025.

Based on Walleye Capital's 13F filing for Q1 2025, filed 14 May 2025.